<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="41841">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01876524</url>
  </required_header>
  <id_info>
    <org_study_id>tRNS01072013</org_study_id>
    <nct_id>NCT01876524</nct_id>
  </id_info>
  <brief_title>tRNS in Anterior Cingulate Cortex Reduces Craving Over Dual Pathology Patients</brief_title>
  <acronym>tRND&amp;SUDs</acronym>
  <official_title>Transcranial Random Noise Stimulation in Anterior Cingulate Cortex Reduces Craving Over Dual Pathology Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Spanish Foundation for Neurometrics Development</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Neurometrics S.L.</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Spanish Foundation for Neurometrics Development</source>
  <oversight_info>
    <authority>Spain: Ethics Committee</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to study the efficacy and security of noninvasive brain
      stimulation as a new approach for patients with Substance Use Disorders (SUDs) plus other
      psychiatric conditions like ADHD, Schizophrenia, Bipolar disorder, etc.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Background: There is an intimate relationship between addictive behaviors and other mental
      disorders, proven by clinical practice and many epidemiological studies, genetic and
      neuroscience. This gives risk to the diagnosis of Dual Pathology: an addiction and another
      mental disorder.

      Functional neuroimaging studies have shown that anterior cingulate cortex is associated with
      substance´s dependence and craving. Transcranial random noise stimulation (tRNS) stimulates
      parts of the brain and can change it´s activity.

      Researchers are interested in reduce cravings for substance dependence on patients with Dual
      Pathology using tRNS in anterior cingulate cortex.

      Aims: To determine whether tRNS in anterior cingulate cortex can reduce craving over Dual
      Pathology patients.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>July 2013</start_date>
  <completion_date type="Anticipated">March 2014</completion_date>
  <primary_completion_date type="Anticipated">January 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Caregiver, Investigator), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>AMEN Questionnarie</measure>
    <time_frame>Following patients during 3 months after Brain noninvasive estimulation</time_frame>
    <safety_issue>No</safety_issue>
    <description>100 Items Questionnarie subdivided in 5 subscales: basal ganglia, cingulate cortez, temporal cortex, prefrontal cortex and limbic system</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Emotional Visual Event Related Potentials</measure>
    <time_frame>Following patients during 3 months after Brain noninvasive estimulation</time_frame>
    <safety_issue>No</safety_issue>
    <description>Emotional Visual Event Related Potentials responses (time courses and topographies) and ICA components related with them, identified by Mitsar 201M EEG Amplifier using EEGLab software [ Time Frame: brainwaves patterns following an array of visual stimuli (human faces) during a 22 min. examination ]</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>CAGE Adapted to Include Drugs (CAGE-AID)</measure>
    <time_frame>Following 3 months after tRNS brain stimulation</time_frame>
    <safety_issue>No</safety_issue>
    <description>The CAGE-AID is a sensitive screen for alcohol and drug problems.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">225</enrollment>
  <condition>Substance Use Disorder</condition>
  <condition>Attention Deficit Disorder With Hyperactivity</condition>
  <condition>Bipolar Disorder</condition>
  <condition>Schizophrenia</condition>
  <condition>Personality Disorder</condition>
  <arm_group>
    <arm_group_label>tRNS over Anterior Cingulate</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Dual Pathology (Substance Use Disorder plus another psychiatric trait) 75 patients with diagnosed SUDs plus another psychiatric disorder will be receive tRNS in the disease-specific Anterior Cingulate Cortex (ACC), be studied blindly to evaluate the craving reduction after 35 tRNS sessions.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>tRNS applied over DLPFC</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Dual Pathology (Substance Use Disorder plus another psychiatric trait) 75 patients with diagnosed SUDs plus another psychiatric disorder will be receive tRNS in the dorso-lateral-prefrontal-cortex (DLPFC), be studied blindly to evaluate the craving reduction after 35 tRNS sessions.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sham Group</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>75 patients will be receive tRNS sham 35 sessions.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Transcranial Random Noise Stimulation</intervention_name>
    <description>Random Noise Stimulation between 100 and 500 Hz and 400-500 microAmperes are applied over head in particular areas</description>
    <arm_group_label>tRNS over Anterior Cingulate</arm_group_label>
    <arm_group_label>tRNS applied over DLPFC</arm_group_label>
    <arm_group_label>Sham Group</arm_group_label>
    <other_name>tRNS, tES</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  &gt; 18 years old and less than 60 years

          -  Best-practice diagnosed Dual Pathology

          -  Diagnosed since at least two years prior to enrollment.

          -  Abuse more than 2 Substances

        ExclusionC riteria:

          -  Serious visual and hearing loss

          -  Brain injury following cranial trauma

          -  Other neurological disorders like Parkinson, ME, headache, etc.

          -  Birth trauma

          -  Mental retardation

          -  Pregnant
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Moises Aguilar-Domingo, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Spanish Foundation for Neurometrics Development</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Moises Aguilar-Domingo, PhD</last_name>
    <phone>968967989</phone>
    <phone_ext>0034</phone_ext>
    <email>moises.aguilar@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Pedro Gurillo-Muñoz, PhD</last_name>
    <phone>634548720</phone>
    <phone_ext>0034</phone_ext>
    <email>pedgurmun2@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Slow Environment Foundation</name>
      <address>
        <city>Cartagena</city>
        <state>Murcia</state>
        <zip>30310</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Pedro Gurillo-Muñoz, PhD</last_name>
      <phone>968972984</phone>
      <email>pedgurmun2@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Moises Aguilar Domingo, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <link>
    <url>http://www.qeeg.es</url>
    <description>Neurometrics</description>
  </link>
  <link>
    <url>http://www.brainmech.org</url>
    <description>Spanish Foundation for Neurometrics Development</description>
  </link>
  <link>
    <url>http://www.fentorno.org</url>
    <description>Slow Environment Foundation</description>
  </link>
  <link>
    <url>http://www.ffis.es</url>
    <description>Fundación para la Formación e Investigación Sanitarias de la Región de Murcia</description>
  </link>
  <results_reference>
    <citation>Soria Aledo V, Aguilar Domingo M, García Cuadrado J, Carrasco Prats M, González Martínez P. [Spontaneous rupture of the spleen: a rare form of onset of non-Hodgkin's lymphoma]. Rev Clin Esp. 1999 Aug;199(8):552-3. Spanish.</citation>
    <PMID>10522446</PMID>
  </results_reference>
  <verification_date>June 2013</verification_date>
  <lastchanged_date>June 12, 2013</lastchanged_date>
  <firstreceived_date>June 10, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Substance Use Disorder</keyword>
  <keyword>Attention Deficit Disorder With Hyperactivity</keyword>
  <keyword>Schizophrenia</keyword>
  <keyword>Bipolar disorder</keyword>
  <keyword>Personality disorder</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Bipolar Disorder</mesh_term>
    <mesh_term>Personality Disorders</mesh_term>
    <mesh_term>Schizophrenia</mesh_term>
    <mesh_term>Substance-Related Disorders</mesh_term>
    <mesh_term>Attention Deficit Disorder with Hyperactivity</mesh_term>
    <mesh_term>Hyperkinesis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
